Roivant Sciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Roivant Sciences 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ROIV

Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. 

CEO
Matthew Gline
CEOMatthew Gline
Employees
750
Employees750
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
2021
Founded2021
Employees
750
Employees750

ROIV Key Statistics

Market cap
20.41B
Market cap20.41B
Price-Earnings ratio
-24.77
Price-Earnings ratio-24.77
Dividend yield
Dividend yield
Average volume
5.01M
Average volume5.01M
High today
$28.94
High today$28.94
Low today
$28.30
Low today$28.30
Open price
$28.75
Open price$28.75
Volume
1.92M
Volume1.92M
52 Week high
$29.20
52 Week high$29.20
52 Week low
$8.73
52 Week low$8.73

Stock Snapshot

The current Roivant Sciences(ROIV) stock price is $28.52, with a market capitalization of 20.41B. The stock trades at a price-to-earnings (P/E) ratio of -24.77.

On 2026-03-02, Roivant Sciences(ROIV) stock moved within a range of $28.30 to $28.94. With shares now at $28.52, the stock is trading +0.8% above its intraday low and -1.5% below the session's peak.

Trading activity shows a volume of 1.92M, compared to an average daily volume of 5.01M.

Over the past 52 weeks, Roivant Sciences(ROIV) stock has traded between a high of $29.20 and a low of $8.73.

Over the past 52 weeks, Roivant Sciences(ROIV) stock has traded between a high of $29.20 and a low of $8.73.

Analyst ratings

83%

of 12 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

People also own

Based on the portfolios of people who own ROIV. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.